This company has been marked as potentially delisted and may not be actively trading. (TMH) (TMH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock TMH vs. DGX, LH, DVA, CHE, CRVL, AMED, MD, AMN, and CCRNShould you be buying (TMH) stock or one of its competitors? The main competitors of (TMH) include Quest Diagnostics (DGX), Laboratory Co. of America (LH), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), and Cross Country Healthcare (CCRN). These companies are all part of the "health care services" industry. (TMH) vs. Quest Diagnostics Laboratory Co. of America DaVita Chemed CorVel Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Quest Diagnostics (NYSE:DGX) and (TMH) (NYSE:TMH) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, community ranking, media sentiment, profitability, analyst recommendations, risk and valuation. Do analysts rate DGX or TMH? Quest Diagnostics currently has a consensus price target of $185.07, suggesting a potential upside of 3.99%. Given Quest Diagnostics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Quest Diagnostics is more favorable than (TMH).Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quest Diagnostics 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.69(TMH) 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals believe in DGX or TMH? 88.1% of Quest Diagnostics shares are owned by institutional investors. 8.2% of Quest Diagnostics shares are owned by insiders. Comparatively, 1.3% of (TMH) shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is DGX or TMH more profitable? Quest Diagnostics has a net margin of 8.80% compared to (TMH)'s net margin of 0.00%. Quest Diagnostics' return on equity of 15.07% beat (TMH)'s return on equity.Company Net Margins Return on Equity Return on Assets Quest Diagnostics8.80% 15.07% 6.72% (TMH) N/A N/A N/A Does the MarketBeat Community believe in DGX or TMH? Quest Diagnostics received 97 more outperform votes than (TMH) when rated by MarketBeat users. However, 74.01% of users gave (TMH) an outperform vote while only 49.14% of users gave Quest Diagnostics an outperform vote. CompanyUnderperformOutperformQuest DiagnosticsOutperform Votes54449.14% Underperform Votes56350.86% (TMH)Outperform Votes44774.01% Underperform Votes15725.99% Which has preferable valuation and earnings, DGX or TMH? Quest Diagnostics has higher revenue and earnings than (TMH). CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuest Diagnostics$10.16B1.96$871M$7.9122.50(TMH)N/AN/AN/AN/AN/A Does the media favor DGX or TMH? In the previous week, Quest Diagnostics had 21 more articles in the media than (TMH). MarketBeat recorded 22 mentions for Quest Diagnostics and 1 mentions for (TMH). Quest Diagnostics' average media sentiment score of 1.18 beat (TMH)'s score of 0.00 indicating that Quest Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quest Diagnostics 14 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive (TMH) 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryQuest Diagnostics beats (TMH) on 13 of the 14 factors compared between the two stocks. Get (TMH) News Delivered to You Automatically Sign up to receive the latest news and ratings for TMH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMH vs. The Competition Export to ExcelMetric(TMH) Industry SectorNYSE ExchangeMarket CapN/A$2.72B$2.46B$19.21BDividend YieldN/A13.15%13.16%4.01%P/E RatioN/A11.2510.9633.50Price / SalesN/A2,184,334.563,514,204.8629.16Price / CashN/A17.2759.3917.52Price / BookN/A3.123.424.55Net IncomeN/A$38.79M-$333.59M$1.02B (TMH) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMH(TMH)N/A$51.84+0.4%N/AN/A$0.00N/A0.00N/ADGXQuest Diagnostics4.6486 of 5 stars$175.92+1.4%$183.73+4.4%+29.5%$19.63B$10.16B22.8849,000Short Interest ↑Positive NewsLHLaboratory Co. of America4.4421 of 5 stars$228.54+2.0%$268.77+17.6%+23.1%$19.12B$13.01B25.9175,500Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews CoveragePositive NewsDVADaVita4.2754 of 5 stars$139.64+0.5%$166.33+19.1%+4.8%$11.17B$12.82B13.0070,000News CoveragePositive NewsCHEChemed4.5972 of 5 stars$546.34-6.7%$667.00+22.1%+2.5%$7.98B$2.43B27.6114,200News CoveragePositive NewsHigh Trading VolumeCRVLCorVel0.9714 of 5 stars$111.17-3.0%N/A+38.6%$5.71B$871.31M65.394,230News CoveragePositive NewsHigh Trading VolumeAMEDAmedisys2.9457 of 5 stars$94.27+0.7%$100.75+6.9%+4.3%$3.09B$2.35B37.4120,000Positive NewsMDPediatrix Medical Group2.0354 of 5 stars$12.50+1.9%$16.75+34.0%+38.7%$1.07B$2.01B-10.427,850Upcoming EarningsAMNAMN Healthcare Services4.265 of 5 stars$18.60+2.4%$38.67+107.9%-64.3%$710.32M$2.98B-4.834,230Upcoming EarningsAnalyst RevisionNews CoverageCCRNCross Country Healthcare3.6274 of 5 stars$13.94-0.4%$18.41+32.0%-18.4%$457.41M$1.34B-278.742,700Upcoming EarningsAnalyst ForecastNews CoveragePositive News Related Companies and Tools Related Companies DGX Alternatives LH Alternatives DVA Alternatives CHE Alternatives CRVL Alternatives AMED Alternatives MD Alternatives AMN Alternatives CCRN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:TMH) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (TMH) Please log in to your account or sign up in order to add this asset to your watchlist. Share (TMH) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.